Canada markets closed

PsyBio Therapeutics Corp. (PSYBF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0060-0.0019 (-24.05%)
At close: 09:55AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0079
Open0.0060
BidN/A x N/A
AskN/A x N/A
Day's Range0.0060 - 0.0060
52 Week Range0.0030 - 0.0521
Volume2,130
Avg. Volume15,260
Market Cap716,286
Beta (5Y Monthly)0.66
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

    PsyBio continues to develop psycho-targeted, biosynthesized tryptamines and with this authorization becomes the first biotechnology company to obtain government sanctioned, formal, written authorization to manufacture biosynthetic tryptamines including PsyBio-11142 at scale Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - July 21, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon disco

  • Newsfile

    PsyBio Announces Closing of Third Tranche of Private Placement

    Oxford, Ohio and Denver, Colorado--(Newsfile Corp. - April 20, 2023) - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company focused upon discovery and development of novel psycho-targeted therapeutics being designed to improve mental health and neurological conditions, is pleased to announce that the Company has completed the third tranche of its previously announced non-brokered private placement offering of uni